In recent years, open access has provided new audiences, including patients, the general public and doctors in low and middle income countries (LMICs), with direct, free access to the results of scientific research.
Featuring China’s Plan S endorsement, an assessment of YODA and the value of preprints to junior researchers
Featuring the researcher cast out for investigating his institution’s predatory publishing habits, the end of the replication crisis, and how to have your say on Plan S.
A new reference site from Medical Publishing Insights and Practices (MPIP) aims to educate its users on the ins and outs of open access as part of its commitment to improving research transparency in pharma. With open access everywhere nowadays, it is very important to know what it is and how it works. However, this … Continue reading MPIP launches new open access toolkit
Featuring peer reviewing robots, the debate over the definition of academic freedom and the scary side of preprints.
Featuring the ways publishers can help authors to escape admin work, researchers’ protests against Plan S and a new tool to assist authors to meet open access policy requirements.
Featuring the newest adherents to Plan S, how to make sure your data are re-useable and whether or not open access policies actually work.
Featuring how libraries can support Plan S implementation, the Incentivization Blueprint encouraging funders to align with the principles of open research, and the effect on citation performance of a journal becoming open access.
This Open Access Week 2018 special edition of the Open Pharma digest features an interactive dashboard of open access data, the cost of open access publishing for research funders, and the latest on Plan S.
Featuring the Royal Society’s plan to combat the replication crisis, a new peer review tool for BMC journals, and the Open Pharma podcast!